pillbase.ru

Trodelvy

Active substance: sacituzumab govitecan

sacituzumab govitecan

Centralised EU authorisationActive

Marketing holder: Gilead Sciences Ireland UC

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 1
  • TRODELVY
    POWDER, FOR SOLUTION · SACITUZUMAB GOVITECAN 180 mg/1
    55135-132
    Gilead Sciences, Inc.
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1209b-33d3-776f-9229-23f59f123d82;count=1 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/005182
Registration status
Active
ATC code
L01FX06
Sources
  • product · EMA · EMEA/H/C/005182 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/005182 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/005182 · Verified 2026-10-09